Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Pharmaceutical industry seeks savings through simplification rather than a radical regulatory overhaul at transatlantic trade talks
Expands its presence in Latin America
Rising prosperity is driving an expansion of the healthcare infrastructure in Turkey, allowing manufacturers to move away from traditional generics and into contract manufacturing and R&D as well as export markets
Will be expanding operational, packaging and storage facilities
The company expects to start building the new facility early next year
Comparative testing to demonstrate efficacy is mandatory for biosimilars, but time to market is key to commercial success. Martin Lamb, Biotec Services, examines areas where supply chain design and management can help reduce the risk of delays in such studies
Biomarker specialist changes its name to confirm its shift towards personalised medicine
The industry faces rising costs for clinical trials on drugs designed to treat ever more complex diseases but with lower returns. Susan Birks reports on what is being done to stem the high failure rates and increase transparency
Suitable for stirred or non-stirred high pressure applications
The biologics market is expected to outpace that of small molecules over the coming years but their large size and complex structures make biologics generally more difficult to manufacture and characterise. Steve Taylor, AB Sciex, reviews recent advances in their analysis and assay development
A magnetic technology for bioseparations and studies of biomolecular interactions
In a rapidly changing global marketplace the pharmaceutical industry will have to improve efficiency levels and raise standards to keep pace with demand from developing economies, says the latest CPhI Pharma Insights report on Pharma Manufacturing